ALKS

E597289

ALKS is the stock ticker symbol for Alkermes plc, a biopharmaceutical company focused on developing medicines for central nervous system diseases and oncology.

All labels observed (2)

Label Occurrences
ALKS canonical 2
NASDAQ:ALKS 1

How this entity was disambiguated

Statements (42)

Predicate Object
instanceOf biopharmaceutical company
stock ticker symbol
country Ireland
currencyOfStock USD
develops CNS therapeutics
oncology therapeutics
engagesIn drug commercialization
drug development
drug discovery
focusesOn central nervous system diseases
oncology
foundedBy Michael Wall
foundingDate 1987
hasADR American depositary shares traded on NASDAQ as ALKS
hasCUSIP G01767105
hasEmployeeRange 1000-5000 employees
hasISIN IE00B56GVS15
hasOffice Waltham, Massachusetts, United States
hasPipeline CNS drug candidates
oncology drug candidates
headquartersLocation Dublin, Ireland
linked to: Dublin
industry biotechnology
pharmaceuticals
legalForm public limited company
listedOn Nasdaq Stock Market
linked to: NASDAQ
marketRegion Europe
United States
notableProduct Aristada
Lybalvi
Vivitrol
regulatoryFiling SEC registrant in the United States
represents Alkermes plc
linked to: Alkermes
researchFocus immuno-oncology
neuroscience
stockTicker ALKS
therapeuticArea alcohol dependence
bipolar I disorder
cancer
major depressive disorder
opioid dependence
schizophrenia
tradedAs NASDAQ:ALKS
linked to: ALKS

How these facts were elicited

Referenced by (3)

Full triples — surface form annotated when it differs from this entity's canonical label.

Alkermes tickerSymbol ALKS
Alkermes plc tradedAs NASDAQ:ALKS
subject linked to: ALKS
linked to: ALKS
Alkermes plc stockTicker ALKS
subject linked to: ALKS